You are here » Home » Companies » Company Overview » Celestial Biolabs Ltd

Celestial Biolabs Ltd.

BSE: 532871 Sector: Health care
NSE: CELESTIAL ISIN Code: INE221I01017
BSE 00:00 | 20 Mar 6.30 -0.04
(-0.63%)
OPEN

6.49

HIGH

6.49

LOW

6.20

NSE 00:00 | 20 Mar 6.25 0
(0.00%)
OPEN

6.10

HIGH

6.40

LOW

6.10

OPEN 6.49
PREVIOUS CLOSE 6.34
VOLUME 4841
52-Week high 21.50
52-Week low 4.33
P/E 4.09
Mkt Cap.(Rs cr) 14
Buy Price 6.21
Buy Qty 200.00
Sell Price 6.36
Sell Qty 25.00
OPEN 6.49
CLOSE 6.34
VOLUME 4841
52-Week high 21.50
52-Week low 4.33
P/E 4.09
Mkt Cap.(Rs cr) 14
Buy Price 6.21
Buy Qty 200.00
Sell Price 6.36
Sell Qty 25.00

Celestial Biolabs Ltd. (CELESTIAL) - Chairman Speech

Company chairman speech

Dear Members

We have range of single and multiple herbal and sea based formulations. Clinicallyvalidated products provide the details of safety and efficacy. These clinically validatedproducts install sufficient confidence among consumers as they get appropriate value fortheir money. Celestial plans to have at least 25 clinically validated multiple herbalformulations that can get certification from CCRAS Ministry of Ayush.

Biophrama scenario and our products

Anti diabetes formulations derived from sea weed extract is clinically tested andpatented products. This product is making penetration in Indian market .Anti arthritis andBiovita have already made an established mark in the market .Herbal and Enzymeformulations can also be marketed worldwide by using online platform along with off linepresent marketing activities We are moving in synergy by improving our supply chain andalso introducing new control measures. We have already started advertising our Leadresearch product called Cadalmin GAE Our effort is continuing to establish OTC market forall our products. We shall spread our domestic marketing in another 12 states during thenext year

Biopharmaceutical in India and rest of the world has made significant improvement. Weare addressing with great care to revamp our business model. Pharma industry shall be ableto keep the pace with the good quality products as there is always demand for such qualitypharma products. Our most of the products are very effective and we are making everyeffort to meet the demand. We are developing effective supply chain management byintroducing new distributors and stockiest at different places. We are also introducingincentive scheme to stockist sales person in order to increase the volume of sales

The biopharmaceutical market is highly competitive. In order to have a competitiveedge our facility at Biotech park an integrated facility clubbed with R&D andproduct development of innovative project shall be the key factor. We will continue topursue our R&D initiative in peptide Enzymes and protein and proceed withmanufacturing of these products at new facility at SEZ Biotech park. This will provide usan opportunity to market our products in Domestic and overseas market.

Initiative

Every effort and established processes are in place towards brand building andadvertising to handle OTC marketing We are able to build better volume by Strengtheningthe manufacturing marketing and distribution We are in the process of meeting WHOstamping on the premier products and that shall provide us an opportunity to market ourproducts in African and south East Asian countries attracting premier pricing.. Reachingeverywhere through C&F and distributors is an difficult proposition and online saleswill take us at every corner of India. Feed supplement to cattle s poultry and fisheriesis an major task to us and celestial is continuously trying to improve the reach andincrease the range of feed supplements in order to spread the sale of feed supplementsacross India.

Effective Human Resource

This aspect is a recognized tool to increase productivity. Effective and Qualitymanpower and their retention is always an challenging task and addressing this taskcarefully shall increase the productivity. We have taken very careful steps to retain onlyquality dedicated and efficient staff. Training courses and sending them to variousseminars and symposium shall also be our priority and thus we will ensure professionalskill development. We have taken a Person with Company secretary and chartered accountancyqualification and also are in the process of recruiting Business development and Researchand developmental professionals

Research initiatives and collaborative effort

Innovation and development cost is becoming more and more and day by day and it needsan optimization effort to reduce the cost..Collaborative research is essential for acompany like us so that we can always fulfill our research objective most economically andeffectively. We are also developing collaborations with CSIR and ICAR and ICMR andUniversities and institutions to develop the Biotech products. Collaborative researchprojects with these premier research organization shall provide a competitive edge andalso increase our learning graph having association with very experienced Researchscientists of these prominent institutions.. We are also installing software at eachC&F in all the states to make our monitoring and control more effective.ly We aremaking every effort to complete the remaining work at city and Biotech park facility sothat production supply chain can be improved in order to increase the business volume.CMFRI Kochin association has given us Cadalmin a great product. Cadalmin efficacy is sohigh that people suffering from arthritis are getting tremendous relief. Further we aremoving to launch a much needed research product to treat diabetes. Lalita college ofpharmacy having extremely good animal house and accredited testing facility have beenidentified as one of the clinical research partner to conduct animal testing for our Ayushapproved products.

Value to the shareholders

Shareholders are very important to us. We always keep shares holders interest onpriority and would like to ensure all our shares holders shall be benefitted immensely.Increasing the investor wealth is our top priority and we will make rapid progress towardsachieving our objective once our capital project is completed. We always address anycomplaint by shareholders very promptly in order to increase share holders value we arein the process of reorganizing our research and manufacturing.

Corporate Social responsibility

Good industries need to support social cause. We are providing medicines on averyconcessional rate to under privileged and handicap people who cannot afford to buy theexpensive medicines. This distribution is being done in villages through AWAKE RESEARCHand SERVICE FOUNDATION a voluntary and social organization. We are also making effort tobuy herbal raw material from farmers driven source directly by giving value to farmers andalso ensuring good quality of raw material. There is very good response from farmers towork on contract farming to grow medicinal plants and shall be moving shortly to have suchagreement with farmers cooperative society. Developing raw material through contractfarming by involving farmers shall be our continuous effort so that farmers can bebenefitted.

Acknowledgment

We always appreciate and acknowledge the valuable input and advice from ourshareholders we thank all our shareholders stake holders staff and business associatesfor their continued support and look forward to your valuable advice to achieve ourobjective at regular interval

Dr A N Singh